Paradigm Asset Management Co. LLC lessened its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 47,108 shares of the biopharmaceutical company’s stock after selling 1,200 shares during the period. Bristol-Myers Squibb makes up approximately 0.6% […]